Nasdaq · Healthcare
LAKELAND INDUSTRIES INC (LAKE)
As-reported financials and recent SEC filings for LAKELAND INDUSTRIES INC, latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$192.6M
Net income
$-25.3M
Net margin
-13.1%
Diluted EPS
$-2.63
ROE
-19.6%
P/E (TTM)
—
Market cap
—
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $192.6M | $167.2M | $124.7M | $112.8M | $118.4M |
| Gross profit | $63.3M | $68.7M | $51.2M | $45.8M | $50.9M |
| Operating income | $-15.5M | $-9.3M | $6.0M | $5.5M | $16.0M |
| Net income | $-25.3M | $-18.1M | $5.4M | $1.9M | $11.4M |
| Diluted EPS | $-2.63 | $-2.43 | $0.72 | $0.24 | $1.41 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-18
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →Largest Healthcare peers
Go deeper on LAKE
Search LAKELAND INDUSTRIES INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.